Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Emeritus Professor David Bates.

Newcastle AuthorsTitleYearFull text
Dr Clare Tolley
Dr Sarah Slight
Professor Andy Husband
Neil Watson
Emeritus Professor David Bates
et al.
Improving medication-related clinical decision support2018
Dr Sarah Slight
Emeritus Professor David Bates
Medication-related clinical decision support alert overrides in inpatients2018
Emeritus Professor David Bates
Lord Walton of Detchant Obituary2016
Emeritus Professor David Bates
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy2014
Emeritus Professor David Bates
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)2013
Emeritus Professor David Bates
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool2013
Emeritus Professor David Bates
Effects of natalizumab treatment on freedom from disease activity by baseline characteristics in AFFIRM2013
Emeritus Professor David Bates
A Risk-Benefit Analysis of Natalizumab Across PML Risk Sub-Groups in Patients with Relapsing-Remitting Multiple Sclerosis2012
Emeritus Professor David Bates
Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Replapsing-Remitting Multiple Sclerosis in Sweden2012
Emeritus Professor David Bates
Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity2012
Emeritus Professor David Bates
Long-term outcomes in patients with multiple sclerosis2011
Emeritus Professor David Bates
Methodology and validation of urinary incontinence in multiple sclerosis screening tool2011
Emeritus Professor David Bates
Registry data2011
Emeritus Professor David Bates
Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials2011
Emeritus Professor David Bates
The value of uniform MRI protocols in the management and treatment of MS in the West2010
Emeritus Professor David Bates
Invited lecture 6: The future of therapy in multiple sclerosis2009
Emeritus Professor David Bates
Professor John Isaacs
Should neurologists wait and see or see and treat RRMS?2009
Emeritus Professor David Bates
Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode2009
Emeritus Professor David Bates
Future therapies in multiple sclerosis2008
Emeritus Professor David Bates
Future therapies in multiple sclerosis2008
Dr Vanessa Hogan
Dr Kathleen White
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
Dr Philip Nichols
et al.
An increase in axonal mitochondrial density may play a role in axonal loss following myelin degeneration in the Plp1 mouse model of demyelination2007
Professor Patrick Chinnery
Dr Douglas Crompton
Dr Margaret Jackson
Emeritus Professor David Bates
Professor Sir John Burn
et al.
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation2007
Emeritus Professor David Bates
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring2007
Emeritus Professor David Bates
Can somatosensory evoked potentials and neuron-specific enolase reliably predict outcome in postanoxic coma? Commentary2006
Dr Helen Andrews
Dr Kathryn White
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
Dr Philip Nichols
et al.
Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse2006
Emeritus Professor David Bates
Natalizumab in relapsing multiple sclerosis: appropriate patient selection, management guidelines, and a diagnostic algorithm for the differential diagnosis of new neurologic signs or symptoms2006
Dr Helen Andrews
Dr Kathleen White
Christopher Thomson
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
et al.
A role for mitochondria in axonal loss in multiple sclerosis: studies in the Shiverer mouse model2005
Dr Philip Nichols
Dr Helen Andrews
Dr Kathleen White
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
et al.
A role for mitochondria in chronic axonal loss in multiple sclerosis: Studies at early and late time points in the shiverer mouse model2005
Dr Helen Andrews
Dr Kathleen White
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
Dr Philip Nichols
et al.
A role for mitochondria in chronic axonal loss in multiple sclerosis: studies at early and late time points in the shiverer mouse model2005
Emeritus Professor David Bates
Disease management in multiple sclerosis2005
Emeritus Professor David Bates
Disease management in multiple sclerosis2005
Dr Helen Andrews
Dr Kathleen White
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
Dr Philip Nichols
et al.
Mitochondria and axonal loss in multiple sclerosis: the missing link?2005
Dr Helen Andrews
Dr Kathleen White
Christopher Thomson
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
et al.
Mitochondria and axonal loss in multiple sclerosis: the shiverer mouse as a model of secondary progressive MS2005
Dr Helen Andrews
Dr Philip Nichols
Emeritus Professor David Bates
Emeritus Professor Doug Turnbull
Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis2005
Dr Douglas Crompton
Professor Patrick Chinnery
Emeritus Professor David Bates
Dr Timothy Walls
Dr Margaret Jackson
et al.
Spectrum of movement disorders in neuroferritinopathy2005
Dr Daniel Birchall
Emeritus Professor David Bates
Emerita Professor Katherine Bushby
Professor Patrick Chinnery
Subclinical semitendinosus and obturator externus involvement defines an autosomal dominant myopathy with early respiratory failure2005
Emeritus Professor David Bates
The vegetative state and the Royal College of Physicians guidance2005
Dr Mark Baker
Professor John Isaacs
Dr Peter Fawcett
Emeritus Professor David Bates
Treatment of stiff person syndrome with rituximab2005
Dr Martin Barron
Philip Griffiths
Emeritus Professor Doug Turnbull
Emeritus Professor David Bates
Dr Philip Nichols
et al.
The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head2004
Emeritus Professor David Bates
The way forward to treatment optimisation in multiple sclerosis: Introduction2004
Dr Martin Barron
Emeritus Professor Doug Turnbull
Emeritus Professor David Bates
Dr Philip Nichols
[abstract] Neuronal loss in Multiple Sclerosis: Role of Mitochondria in the Axonal response to Demyelination2003
Dr Hazel Powell
Dr Sally Lynch
Emeritus Professor David Bates
Dr Ann Curtis
A deletion within the frataxin gene, combined with a GAA expansion mutation causes atypical Friedreich ataxia2003
Emeritus Professor David Bates
The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis2003
Emeritus Professor David Bates
The vegetative state: guidance on diagnosis and management - A report of a working party of the Royal College of Physicians2003
Professor Patrick Chinnery
Andrew Curtis
Constanze Fey
Dr Margaret Jackson
Emeritus Professor David Bates
et al.
Neuroferritinopathy2002
Dr Douglas Crompton
Professor Patrick Chinnery
Constanze Fey
Andrew Curtis
Dr Christopher Morris
et al.
Neuroferritinopathy: A window on the role of iron in neurodegeneration2002
Professor Patrick Chinnery
Dr Timothy Walls
Professor Michael Hanna
Emeritus Professor David Bates
Dr Peter Fawcett
et al.
Normokalemic periodic paralysis revisited: Does it exist?2002
Andrew Curtis
Constanze Fey
Dr Christopher Morris
Professor Laurence Bindoff
Professor Patrick Chinnery
et al.
Mutation in ferritin light chain causes dominant adult onset neurodegeneration2001
Andrew Curtis
Constanze Fey
Dr Christopher Morris
Professor Laurence Bindoff
Professor Patrick Chinnery
et al.
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease2001
Emeritus Professor David Bates
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS2001
Emeritus Professor David Bates
Randomized controlled trial of interferon-beta-1a in secondary progressive MS - Clinical results2001
Emeritus Professor David Bates
The prognosis of medical coma2001
Professor Sir John Burn
Andrew Curtis
Dr Matthew Jackson
Constanze Fey
Emeritus Professor David Bates
et al.
A novel autosomal dominant basal ganglia degeneration with cavitation on 19q can mimic Parkinson's disease and Huntington's disease2000
Dr David Parkin
Emeritus Professor David Bates
Costs and quality of life in multiple sclerosis: a cross-sectional observational study in the UK2000
Emeritus Professor David Bates
Professor Simon Thomas
Multiple sclerosis: care needs for 2000 and beyond2000
Dr David Parkin
Dr Ann Jacoby
Paul McNamee
Paul Miller
Professor Simon Thomas
et al.
Treatment of multiple sclerosis with interferon β: An appraisal of cost-effectiveness and quality of life2000
Professor David Burn
Emeritus Professor David Bates
Quantitative analysis of MRI signal intensity in new variant Creutzfeldt-Jakob disease1999
Professor Robert Taylor
Professor Patrick Chinnery
Emeritus Professor David Bates
Dr Margaret Jackson
Dr Margaret Johnson
et al.
A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: Studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis1998